V

Viking Therapeutics
D

VKTX

34.090
USD
2.48
(7.85%)
مغلق
حجم التداول
769,207
الربح لكل سهم
-2
العائد الربحي
-
P/E
-36
حجم السوق
3,803,541,263
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    G
    GNFT
    -0.12000
    (-3.05%)
    3.82000 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    المزيد
الأخبار
المقالات

العنوان: Viking Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.